Reply to Sharma et Al and Saukkonen et Al
- PMID: 20560741
- DOI: 10.1086/653682
Reply to Sharma et Al and Saukkonen et Al
Comment on
-
Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.Clin Infect Dis. 2010 Mar 15;50(6):833-9. doi: 10.1086/650576. Clin Infect Dis. 2010. PMID: 20156055 Clinical Trial.
Similar articles
-
Challenges in reintroducing tuberculosis medications after hepatotoxicity.Clin Infect Dis. 2010 Mar 15;50(6):840-2. doi: 10.1086/650577. Clin Infect Dis. 2010. PMID: 20156056 No abstract available.
-
[Hepatic function and antitubercular drugs].Clin Ter. 1978 Sep 15;86(5):495-501. Clin Ter. 1978. PMID: 367684 Review. Italian. No abstract available.
-
[Antitubercular drug-induced liver injuries].Zhonghua Jie He He Hu Xi Za Zhi. 1998 May;21(5):308-9. Zhonghua Jie He He Hu Xi Za Zhi. 1998. PMID: 11326960 Review. Chinese. No abstract available.
-
[Liver and antitubercular drug therapy].Rev Fac Cienc Med Cordoba. 1974 Jan-Mar;32(1):19-36. Rev Fac Cienc Med Cordoba. 1974. PMID: 4458009 Spanish. No abstract available.
-
[Tuberculostatic agents].Ned Tijdschr Geneeskd. 1987 Oct 17;131(42):1845-9. Ned Tijdschr Geneeskd. 1987. PMID: 3670495 Dutch. No abstract available.
Cited by
-
Clinicopathological correlates in HIV seropositive tuberculosis cases presenting with jaundice after initiating antiretroviral therapy with a structured review of the literature.BMC Infect Dis. 2012 Oct 14;12:257. doi: 10.1186/1471-2334-12-257. BMC Infect Dis. 2012. PMID: 23061403 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical